Presentation is loading. Please wait.

Presentation is loading. Please wait.

Delineating cancer evolution with single-cell sequencing

Published byΛάχεσις Δαμασκηνός Modified over 5 years ago

Similar presentations

Presentation on theme: "Delineating cancer evolution with single-cell sequencing"— Presentation transcript:

1 Delineating cancer evolution with single-cell sequencing
by Nicholas E. Navin Sci Transl Med Volume 7(296):296fs29-296fs29 July 15, 2015 Copyright © 2015, American Association for the Advancement of Science

2 Fig. 1 No tumor cells are identical.
No tumor cells are identical. Whole-genome single-cell sequencing of four tumor cells from an estrogen receptor–positive breast cancer patient shows that no two tumor cells are genetically identical. Clonal mutations are shown in black, subclonal mutations in intergenic regions are colored in red, and subclonal mutations in exonic regions are shown in green. Nicholas E. Navin Sci Transl Med 2015;7:296fs29 Copyright © 2015, American Association for the Advancement of Science

Download ppt "Delineating cancer evolution with single-cell sequencing"

Similar presentations

Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? by Stephen F. Kingsmore, and Carol J. Saunders Sci Transl Med Volume.

Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? by Stephen F. Kingsmore, and Carol J. Saunders Sci Transl Med Volume.
Increasingly detailed genomic data from successive generations of DNA sequencing technology reveal the clonal structure of cancer cell populations. Early.

Increasingly detailed genomic data from successive generations of DNA sequencing technology reveal the clonal structure of cancer cell populations. Early.
Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.

Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.
سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer
Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery.

Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery.
Nicholas McGranahan, Charles Swanton  Cell 

Nicholas McGranahan, Charles Swanton  Cell 
Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.

Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.
Darwinian evolution and tiding clones in multiple myeloma

Darwinian evolution and tiding clones in multiple myeloma
Representative CT and PET/CT images of three patients with NSCLCs

Representative CT and PET/CT images of three patients with NSCLCs
Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies  Francesca L. Nice,

Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies  Francesca L. Nice,
Fig. 3 CSF1 is expressed in human melanoma.

Fig. 3 CSF1 is expressed in human melanoma.
Fig. 7 Correlation of NHP and human ISGs.

Fig. 7 Correlation of NHP and human ISGs.
Fig. 1. Distribution of TTNtv in healthy individuals and DCM patients, and TTN exon usage in the heart. Distribution of TTNtv in healthy individuals and.

Fig. 1. Distribution of TTNtv in healthy individuals and DCM patients, and TTN exon usage in the heart. Distribution of TTNtv in healthy individuals and.
Consolidated Standards of Reporting Trials flow diagram of VRC trial

Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.

Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.

Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 4 Gene disruption via chip.

Fig. 4 Gene disruption via chip.
Fig. 3. Comparison of prediction performance.

Fig. 3. Comparison of prediction performance.
Fig. 7 Bacterial dependency networks in IgA deficiency and HDs.

Fig. 7 Bacterial dependency networks in IgA deficiency and HDs.
Fig. 1. Iontophoretic devices used for the delivery of cytotoxic agents to solid tumors. Iontophoretic devices used for the delivery of cytotoxic agents.

Fig. 1. Iontophoretic devices used for the delivery of cytotoxic agents to solid tumors. Iontophoretic devices used for the delivery of cytotoxic agents.

Similar presentations

Ads by Google